Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Aptamer technology: a new approach to treat lymphoma?
Youli Zu
Academic Institute
Department of Pathology & Genomic Medicine
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aptamer technology: a new approach to treat lymphoma?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lymphoma
100%
Aptamer Technology
100%
Therapeutic Efficacy
33%
Chemotherapy
33%
High Affinity
33%
Clinical Value
33%
Disease Diagnosis
33%
Aptamer
33%
Nucleic Acid Aptamer
33%
Lymphatic System
33%
Targeted Therapy
33%
Protein Antibody
33%
Target Specificity
33%
Small Molecule Ligands
33%
Lymphoma Therapy
33%
Biomedical Studies
33%
Medicine and Dentistry
Aptamer
100%
Side Effect
40%
Diagnosis
20%
Cancer
20%
Combination Therapy
20%
Targeted Therapy
20%
Oligonucleotide
20%
Lymphatic System
20%
Protein Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
100%
Side Effect
40%
Diseases
20%
Combination Therapy
20%
Chemotherapy
20%
Oligonucleotide
20%
Protein Antibody
20%
Biochemistry, Genetics and Molecular Biology
Aptamer
100%
Oligonucleotide
20%
Small Molecule
20%